Deriv of acridine, q.v., with cytostatic and cytotoxic properties. Prepn: FR 1458183 (1966 to Polfa), C.A. 68, 39493s (1968); A. Ledochowski, B. Stefanska, Rocz. Chem. 40, 301 (1966), C.A. 65, 2219b (1966). Pharmacological studies: J. Gieldanowski et al., Arch. Immunol. Ther. Exp. 20, 399 (1972); eidem, ibid. 419. Mechanism of action: J. Konopa et al., Mater. Med. Pol. 8, 258 (1976). Cytotoxicity study: I. Szumiel, M. Walicka, Neoplasma 27, 697 (1980). DNA binding activity: L. Szmigiero, M. Gniazdowski, Arzneim.-Forsch. 31, 1875 (1981). Comprehensive review: M. Gniazdowski et al. in Antibiotics Vol. V, part 2, F. E. Hahn, Ed. (Springer-Verlag, New York, 1979) pp 275-297.
Antineoplastic.
Antineoplastic